Press Releases
In The News
Presentations
QT Imaging shows high resolution images of its technology
QT Imaging CEO to present at leading conference on cancer treatment, testing, and monitoring modalities
QT Imaging and GigCapital5 to Merge
GigCapital5 and QT Imaging have entered into a definitive business combination agreement that would result in QT Imaging becoming a publicly listed company
The QTscan to be used to improve the assessment of tumor response in neo-adjuvant chemotherapy treatments
QT Imaging expected to be public in the first half of 2023
QTscan delivers safe, accurate monitoring of breast cancer treatment.
Study provides a more accurate description of tissue changes during the menstrual cycle – the first time such observations have been made in vivo.
QT Imaging’s low frequency transmitted ultrasound volography™ had sensitivity of 85.7% sensititivity compared to mpMRI at 65.3% in a blinded sector-based analysis.
QT Imaging meets non-inferiority endpoint for mass detection when compared to conventional full field digital mammography (FFDM)
US Capital Global Securities engaged as lead placement agent by innovative MedTech company developing new-paradigm ultrasound technology for breast cancer screening.
QT Imaging signs distribution agreement with Freedom Ventures for its FDA-cleared breast scanner
First-in-class, first-in-human study compares new breast imaging modality to digital mammography
Common mission of safe, advanced, affordable medical imaging brings together international leaders
CEO, John Klock, MD, and Principal Scientist, James Wiskin, Ph.D, Present Innovation in Quantitative Transmission Ultrasound
James Wiskin, Ph.D, QT Ultrasound’s Principal Scientist, invited to lecture on innovative technology
3D Transmission Ultrasound Technology Advances How We Look at Breast Health
QT Ultrasound’s principal scientists and technologists deliver five presentations at key industry event
Chief Medical Officer, Rajni Natesan, MD, MBA and Principal Scientist, Bilal Malik, Ph.D, will introduce cutting edge research at RSNA 2018
The FDA has designated the QT Ultrasound Breast Scanner as meeting an unmet medical need for screening women at high risk for breast cancer
As part of the QT Ultrasound Breast Scanner the new viewer for true 3D breast images offers radiologists clarity, customizable views, faster response time, and powerful research mode.
Transmission ultrasound technology provides 360-degree images and a new level of clarity for breast scans, without breast compression.